ReviewAmerican journal of clinical dermatology2024

The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases.

Jolanta Pach et al.PubMed ↗Publisher ↗

No numbers read from the abstract.